Please ensure Javascript is enabled for purposes of website accessibility
Free Article Join Over 1 Million Premium Members And Get More In-Depth Stock Guidance and Research

How Do COVID Vaccines Impact the Spread of Coronavirus?

By Keith Speights - Dec 19, 2020 at 11:30AM

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

Here's what an immunotherapy scientist has to say about the important question.

The vaccines have landed. After winning Emergency Use Authorization (EUA) over the weekend, Pfizer's ( PFE 2.32% ) COVID-19 vaccine has been shipped across the U.S. with the initial wave of Americans beginning to be vaccinated. But will receiving the vaccine prevent the spread of coronavirus to others? In this Motley Fool Live video recorded on Dec. 11, 2020, healthcare and cannabis bureau chief Corinne Cardina talked with immunotherapy scientist Dr. Leo Nissola about this important question.

Corrine Cardina: Another thing that I think there's a little bit of confusion about is how this vaccine impacts transmission of the virus. Is it possible that you could be vaccinated, then become infected with the coronavirus, but not develop COVID-19 and pass it to someone else?

I think part of the confusion is that the endpoints in these trials have been developing COVID-19, not so much being infected with coronavirus. Is there an important difference here and can you shed a little light?

Dr. Leo Nissola: Yes. That's a $10 million question and one I wish I had the answer to.

Right now, what we know from the data that has been published is that we still believe that folks that have had the vaccine can still transmit the disease in case that they are carrying it. We don't know and until we do, we will still be needing to practice what we know. Social distancing, wearing masks, and avoiding indoors.

This article represents the opinion of the writer, who may disagree with the “official” recommendation position of a Motley Fool premium advisory service. We’re motley! Questioning an investing thesis – even one of our own – helps us all think critically about investing and make decisions that help us become smarter, happier, and richer.

Invest Smarter with The Motley Fool

Join Over 1 Million Premium Members Receiving…

  • New Stock Picks Each Month
  • Detailed Analysis of Companies
  • Model Portfolios
  • Live Streaming During Market Hours
  • And Much More
Get Started Now

Stocks Mentioned

Pfizer Inc. Stock Quote
Pfizer Inc.
PFE
$54.27 (2.32%) $1.23

*Average returns of all recommendations since inception. Cost basis and return based on previous market day close.

Related Articles

Motley Fool Returns

Motley Fool Stock Advisor

Market-beating stocks from our award-winning service.

Stock Advisor Returns
624%
 
S&P 500 Returns
140%

Calculated by average return of all stock recommendations since inception of the Stock Advisor service in February of 2002. Returns as of 12/06/2021.

Discounted offers are only available to new members. Stock Advisor list price is $199 per year.

Our Most Popular Articles

Premium Investing Services

Invest better with the Motley Fool. Get stock recommendations, portfolio guidance, and more from the Motley Fool's premium services.